10 Stocks Soaring by Double Digits; Uranium Stocks Leading

1. Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)

Arcutis jumped to a fresh record high on Tuesday, as investors cheered a stellar earnings performance in the third quarter of the year, having more than doubled its revenues to reach profitability during the period.

In intra-day trading, Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) jumped to its highest 52-week price of $25.75 before trimming gains to end the day just up by 27.04 percent at $24.95 apiece.

This followed announcements that it swung to a net profit of $7.4 million in the third quarter of the year from a $41.5 million net loss in the same period last year.

Total revenues soared by 121 percent to $99 million from $44.7 million in the same comparable period.

For the nine-month period, Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) remained at a net loss of $33.5 million, albeit 74 percent lower than the $129 million year-on-year.

Revenues, on the other hand, surged by 97 percent to $246 million from $125 million.

“This success provides a tremendous foundation for sustained, long-term growth—offering the opportunity to reinvest in the ZORYVE franchise, systematically evaluate new opportunities, and expand our pipeline with new molecules that leverage our deep expertise in dermatology, as well as our best-in-class development and commercialization capabilities,” said President and CEO Frank Watanabe.

For next year, Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) is targeting to generate between $455 million and $470 million in net revenues.

While we acknowledge the potential of ARQT to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ARQT and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge fund investor letters by entering your email below.